136 related articles for article (PubMed ID: 26881519)
21. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
[TBL] [Abstract][Full Text] [Related]
23. High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma.
Xu Y; Rong J; Duan S; Chen C; Li Y; Peng B; Yi B; Zheng Z; Gao Y; Wang K; Yun M; Weng H; Zhang J; Ye S
Sci Rep; 2016 Nov; 6():35948. PubMed ID: 27883022
[TBL] [Abstract][Full Text] [Related]
24. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
25. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
26. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.
He YF; Jin J; Wei W; Chang Y; Hu B; Ji CS; Jia WD; Wang XQ; Chen K; Chen J
Can J Gastroenterol; 2010 Jul; 24(7):435-40. PubMed ID: 20652159
[TBL] [Abstract][Full Text] [Related]
28. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.
Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X
Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723
[TBL] [Abstract][Full Text] [Related]
29. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Aigelsreiter A; Haybaeck J; Schauer S; Kiesslich T; Bettermann K; Griessbacher A; Stojakovic T; Bauernhofer T; Samonigg H; Kornprat P; Lackner C; Pichler M
Hum Pathol; 2012 Jul; 43(7):1012-9. PubMed ID: 22176836
[TBL] [Abstract][Full Text] [Related]
30. Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas.
Zhang JL; Qian YB; Zhu LX; Xiong QR
Asian Pac J Cancer Prev; 2011; 12(12):3265-9. PubMed ID: 22471464
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
[TBL] [Abstract][Full Text] [Related]
32. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
[TBL] [Abstract][Full Text] [Related]
33. Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.
Shin E; Yu YD; Kim DS; Won NH
Pathol Oncol Res; 2014 Jul; 20(3):667-75. PubMed ID: 24619866
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
[TBL] [Abstract][Full Text] [Related]
35. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
36. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
[TBL] [Abstract][Full Text] [Related]
39. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.
Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q
Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy.
Huang YH; Chen ZK; Huang KT; Li P; He B; Guo X; Zhong JQ; Zhang QY; Shi HQ; Song QT; Yu ZP; Shan YF
Asian Pac J Cancer Prev; 2013; 14(3):1985-8. PubMed ID: 23679304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
